ArticleHaematologica2025
Metabolic reprogramming by PRDM16 drives cytarabine resistance in acute myeloid leukemia.
Junji Ikeda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleHaematologica2025
Junji Ikeda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.